Less Ads, More Data, More Tools Register for FREE

Pin to quick picksOryx International Growth Regulatory News (OIG)

Share Price Information for Oryx International Growth (OIG)

Share Price is delayed by 15 minutes
Get Live Data
1,280.00    5.00 (0.39%)
Bid:
1,230.00
Ask:
1,305.00
Spread: 75.00 (6.098%)
Market Cap: £179.20m
OIG Live PriceLast checked at - London Stock Exchange

Intraday Oryx International Growth Share Chart

Interim Management Statement

14 Feb 2014 15:00

RNS Number : 1320A
Oryx International Growth Fund Ld
14 February 2014
 



ORYX INTERNATIONAL GROWTH FUND LIMITED

INTERIM MANAGEMENT STATEMENT

FOR THE QUARTER ENDED 31 DECEMBER 2013

 

 

Oryx International Growth Fund Limited ("Oryx" or the "Company"), is publishing this Interim Management Statement in accordance with DTR 4.3 of the FCA Handbook.

 

This interim management statement has been produced solely to provide additional information to shareholders as a body to meet the relevant requirements of the UK Listing Authority's Disclosure and Transparency Rules. It should not be relied upon by any other party or for any other purpose.

 

This interim management statement relates to the period from 1 October 2013 to 31 December 2013, and contains information that covers this period, and up to the date of publication of this interim management statement, unless otherwise specified.

 

Manager's Review

 

During the period under review, the FTSE Small Cap Index returned 5.07% and the FTSE All-Share Index returned 4.77%. Against this, the Company's net asset value rose by 10.05%, 43p per share. The Company has benefited from the recent improvement in market conditions and we are pleased to report that the net asset value per share has reached an all-time high.

 

As reported previously, a number of the companies in the Unquoted portfolio are in the process of corporate activity.

 

Material Transactions

During the quarter ended 31 December 2013, the Company purchased 1,176,744 shares for the purposes of cancellation.

 

Material Events

There were no material events during the quarter ended 31 December 2013.

 

Report and Accounts

On 25 November 2013, the Company released its Half-year Report and Condensed Consolidated Financial Statements for the six months ended 30 September 2013, to Shareholders.

 

Financial Highlights

 

31-Dec-13

30-Sep-13

30-Jun-13

31-Mar-13

31-Dec-12

30-Sep-12

30-Jun-12

NAV

£4.77

£4.32

£3.85

£3.78

£3.48

£3.22

£2.93

US Dollar /

Sterling Exchange Rate

1.6562

1.6194

1.5167

1.5182

1.6254

1.6148

1.5685

 

Twenty Largest Equity Investments at 31 December 2013

 

DETAILS

% NET ASSETS

GLEESON (M.J.) GROUP PLC

13.60

GOALS SOCCER CENTRES PLC

7.86

REDCENTRIC PLC

6.61

QUARTO GROUP INC

6.08

GUINNESS PEAT GROUP PLC

5.48

BIOQUELL PLC

5.17

JOURNEY GROUP PLC

5.02

CELSIS AG

4.45

ACCUMULI PLC

4.40

MECOM GROUP PLC

4.28

ASSETCO PLC

3.84

CATALYST MEDIA GROUP PLC

3.39

CVS GROUP PLC

2.79

SINAV LIMTED

2.59

OMG PLC

2.54

CYPROTEX PLC

2.28

TELECITY GROUP PLC

1.96

WALKER CRIPS GROUP PLC

1.94

TEAM ROCK PREF GBP SHARES

1.49

AUGEAN PLC

1.14

TOTAL

86.91

 

 

The financial information for the quarter ended 31 December 2013 contained within this Interim Management Statement has not been audited.

 

 

By order of the Board

 

 

 

 

BNP Paribas Securities Services S.C.A., Guernsey Branch

for and on behalf of

Oryx International Growth Fund Limited

as Company Secretary

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
IMSGGUPCPUPCGWC
Date   Source Headline
3rd Aug 20169:15 amRNSNet Asset Value(s)
28th Jul 20165:05 pmRNSNotification of Major Interest in Shares
28th Jul 20163:33 pmRNSHolding(s) in Company
26th Jul 20169:45 amRNSHolding(s) in Company
15th Jul 20167:32 amRNSHolding(s) in Company
13th Jul 20167:00 amRNSAnnual Report and Accounts and Notice of AGM
5th Jul 20161:14 pmRNSHolding(s) in Company
4th Jul 20165:01 pmRNSAnnual Financial Report
4th Jul 20168:18 amRNSHolding(s) in Company
24th Jun 201610:14 amRNSNet Asset Value(s)
3rd Jun 20161:36 pmRNSHolding(s) in Company
27th May 20163:08 pmRNSNet Asset Value(s)
10th May 20165:30 pmRNSTransaction in Own Shares
10th May 20165:30 pmRNSTransactions in a Close Period
28th Apr 201612:22 pmRNSNet Asset Value(s)
29th Mar 20169:37 amRNSNet Asset Value(s)
23rd Feb 20163:36 pmRNSNet Asset Value(s)
18th Feb 201611:07 amRNSForm 8.3 - Tangent Communications plc
28th Jan 20167:00 amRNSDisclosure of Home Member State
25th Jan 201612:19 pmRNSNet Asset Value(s)
18th Jan 201612:41 pmRNSHolding(s) in Company
18th Jan 201611:56 amRNSHolding(s) in Company
15th Jan 20163:11 pmRNSHolding(s) in Company
13th Jan 20169:17 amRNSHolding(s) in Company
18th Dec 20158:02 amRNSNet Asset Value(s)
10th Dec 20157:00 amRNSTR-1: Notification Of Major Interest In Shares
4th Dec 201511:00 amRNSTR-1: Notification of major interest in shares
3rd Dec 201512:28 pmRNSHolding(s) in Company
27th Nov 20153:44 pmRNSHolding(s) in Company - Replacement
24th Nov 20153:17 pmRNSHolding(s) in Company
24th Nov 201510:49 amRNSNet Asset Value(s)
20th Nov 20157:00 amRNSHalf Yearly Report
16th Nov 20156:00 pmRNSPortfolio Update
14th Oct 201512:07 pmRNSNet Asset Value(s)
1st Oct 201511:51 amRNSHolding(s) in Company Replacement
30th Sep 20156:08 pmRNSHolding(s) in Company
21st Sep 201510:38 amRNSNet Asset Value(s)
18th Sep 20154:37 pmRNSHolding(s) in Company
1st Sep 20156:00 pmRNSTransaction in Own Shares
1st Sep 20155:21 pmRNSHolding(s) in Company
27th Aug 201512:48 pmRNSNet Asset Value(s)
25th Aug 20152:15 pmRNSForm 8.3 - EKF Diagnostics Holdings Plc
25th Aug 20151:10 pmRNSHolding(s) in Company
17th Aug 20157:00 amRNSResult of AGM
13th Aug 20153:20 pmRNSHolding(s) in Company
7th Aug 20153:48 pmRNSHolding(s) in Company
7th Aug 20157:00 amRNSHolding(s) in Company
28th Jul 201511:31 amRNSHolding(s) in Company
23rd Jul 20159:41 amRNSNet Asset Value(s)
20th Jul 20155:30 pmRNSAnnual Report and Accounts and Notice of AGM

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.